54

Artemis Medicare Services LtdBOM 542919 Stock Report

Last reporting period 31 Mar, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

0.025

Micro

Exchange

XBOM - Bombay Stock Exchange

542919.BO Stock Analysis

54

Avoid

Based on Eyestock quantitative analysis, 542919.BO`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

56/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-69.9 %

Greatly overvalued

Market cap $B

0.025

Dividend yield

0.49 %

Shares outstanding

136.88 B

Artemis Medicare Services Ltd. provides health care services. The company employs 1,937 full-time employees The company went IPO on 2020-01-23. The firm is expertized in the spectrum of advanced medical and surgical interventions, a mix of inpatient and outpatient services. The firm offers treatment facilities for various medical conditions under various specialties, which include allergy and immunology, blood (haematology), bones, muscles and joints (orthopaedics), brain, spine and nervous system, cancer (oncology), circulatory (vascular), dermatology, digestive (gastroenterology), endocrine, diabetes and metabolismheart (cardiology), infectious diseases, kidneys (renal), lung (pulmonary), mouth, teeth and face (oral and maxillofacial), obstetrics and gynaecology, psychiatry, rheumatology (arthritis and joint disease), surgery and urology. The firm's subsidiary includes Artemis Cardiac Care Private Limited.

View Section: Eyestock Rating